Vimedimex Medi – Pharma JSC (STC:VMD) EV-to-OCF: (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vimedimex Medi – Pharma JSC EV-to-OCF?

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Vimedimex Medi – Pharma JSC's Enterprise Value is ₫0.00 Mil. Vimedimex Medi – Pharma JSC does not have enough years/quarters to calculate its Cash Flow from Operations for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Vimedimex Medi – Pharma JSC's EV-to-OCF at this moment.

The historical rank and industry rank for Vimedimex Medi – Pharma JSC's EV-to-OCF or its related term are showing as below:

STC:VMD's EV-to-OCF is not ranked *
in the Biotechnology industry.
Industry Median: -3.41
* Ranked among companies with meaningful EV-to-OCF only.

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-06), Vimedimex Medi – Pharma JSC's stock price is ₫13600.00. Vimedimex Medi – Pharma JSC does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Vimedimex Medi – Pharma JSC's PE Ratio (TTM) at this moment.


Vimedimex Medi – Pharma JSC  (STC:VMD) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Vimedimex Medi – Pharma JSC's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=13600.00/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Vimedimex Medi – Pharma JSC EV-to-OCF Related Terms


Vimedimex Medi – Pharma JSC EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Vimedimex Medi – Pharma JSC's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimedimex Medi – Pharma JSC EV-to-OCF Chart

Vimedimex Medi – Pharma JSC Annual Data
Trend
EV-to-OCF

Vimedimex Medi – Pharma JSC Quarterly Data
EV-to-OCF

Vimedimex Medi – Pharma JSC EV-to-OCF Calculation

Vimedimex Medi – Pharma JSC's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=0.000/
=


Vimedimex Medi – Pharma JSC Business Description

Address 246 Cong Quynh Street, Pham Ngu Lao Ward, District 1, Ho Chi Minh City, VNM
Vimedimex Medi - Pharma JSC is engaged in the production, trading, import, and export of medicines, raw materials for making medicines, biological products, cosmetics, functional foodstuffs, medical equipment, and testing chemicals. It is also involved in renting office buildings; operates bonded warehouses and pharmacy-GSP.